Topchoice Medical Corp.

  • Market Cap: Large Cap
  • Industry: Hospital
  • ISIN: CNE000000MZ8
CNY
41.35
-0.42 (-1.01%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Net Sales
755.29
622.89
841.77
703.83
744.61
640.65
822.55
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
755.29
622.89
841.77
703.83
744.61
640.65
822.55
Raw Material Cost
423.91
469.65
494.50
450.90
415.45
484.21
480.89
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
6.43
5.52
11.88
10.67
7.78
12.46
11.67
Selling and Distribution Expenses
79.70
112.11
67.86
65.26
81.10
109.92
62.08
Other Expenses
0.60
1.16
0.59
0.09
0.42
0.44
0.54
Total Expenditure (Excl Depreciation)
516.05
598.88
580.16
527.76
508.48
610.98
560.01
Operating Profit (PBDIT) excl Other Income
239.20000000000002
24
261.6
176.1
236.1
29.700000000000003
262.5
Other Income
3.56
1.95
3.77
3.62
4.91
2.97
0.48
Operating Profit (PBDIT)
242.33
88.81
330.35
243.12
240.46
93.27
324.51
Interest
6.43
5.52
11.88
10.67
7.78
12.46
11.67
Exceptional Items
0.00
0.90
0.00
0.00
0.00
1.42
0.00
Gross Profit (PBDT)
331.38
153.25
347.27
252.93
329.16
156.44
341.66
Depreciation
0.00
65.26
65.26
66.45
0.00
62.09
62.09
Profit Before Tax
235.91
18.93
253.21
166.00
232.69
20.14
250.75
Tax
21.17
49.23
28.21
15.83
23.79
55.75
26.74
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
186.87
-11.55
192.34
137.23
183.83
3.16
188.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
186.87
-11.55
192.34
137.23
183.83
3.16
188.00
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
33.71
-16.56
43.76
26.97
32.18
-32.79
45.72
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
220.58
-28.12
236.11
164.20
216.01
-29.63
233.71
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
4,420.90
4,234.02
4,343.71
4,150.45
4,209.63
4,027.80
4,126.44
Earnings per share (EPS)
0.41
-0.03
0.43
0.31
0.41
0.01
0.42
Diluted Earnings per share
0.41
-0.03
0.43
0.31
0.41
0.01
0.42
Operating Profit Margin (Excl OI)
31.61%
3.47%
31.05%
24.59%
31.63%
4.4%
31.85%
Gross Profit Margin
31.23%
13.52%
37.83%
33.03%
31.25%
12.83%
38.03%
PAT Margin
24.74%
-1.85%
22.85%
19.5%
24.69%
0.49%
22.86%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Mar 2026 is 1.44% vs 5.11% in Mar 2025

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Mar 2026 is 2.13% vs 5.93% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Mar 2026 is 1.36% vs -20.54% in Mar 2025

stock-summary

Interest

YoY Growth in quarter ended Mar 2026 is -17.95% vs -16.13% in Mar 2025

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Mar 2026 has fallen from Mar 2025

Compare Quarterly Results Of Topchoice Medical Corp. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
755.29
0
755.29
Other Operating Income
0.00
0.00
0.00
Total Operating income
755.29
0
755.29
Raw Material Cost
423.91
0
423.91
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
6.43
0
6.43
Selling and Distribution Expenses
79.70
0
79.70
Other Expenses
0.60
0.00
0.60
Total Expenditure (Excl Depreciation)
516.05
0
516.05
Operating Profit (PBDIT) excl Other Income
239.24
0.00
239.24
Other Income
3.56
0
3.56
Operating Profit (PBDIT)
242.33
0
242.33
Interest
6.43
0
6.43
Exceptional Items
0.00
0
0.00
Gross Profit (PBDT)
331.38
0
331.38
Depreciation
0.00
0
0.00
Profit Before Tax
235.91
0
235.91
Tax
21.17
0
21.17
Provisions and contingencies
0
0
0.00
Profit After Tax
186.87
0
186.87
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
186.87
0
186.87
Share in Profit of Associates
0
0
0.00
Minority Interest
33.71
0
33.71
Other related items
0.00
0.00
0.00
Consolidated Net Profit
220.58
0
220.58
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
4,420.90
0
4,420.90
Earnings per share (EPS)
0.41
0
0.41
Diluted Earnings per share
0.41
0
0.41
Operating Profit Margin (Excl OI)
31.61%
0%
0.00
31.61%
Gross Profit Margin
31.23%
0%
0.00
31.23%
PAT Margin
24.74%
0%
0.00
24.74%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 75.53 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is 21.26% vs -26.00% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 1.44% vs 5.11% in Mar 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit 22.06 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is 885.05% vs -111.90% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 2.13% vs 5.93% in Mar 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 23.88 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is 174.80% vs -73.39% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 1.36% vs -20.54% in Mar 2025

Quarterly - Interest
Interest 0.64 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is 16.36% vs -53.78% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is -17.95% vs -16.13% in Mar 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 31.61%
in Mar 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 has fallen from Mar 2025